Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P050017/S027

Zilver 635 Vascular Stent, Zilver 518 Vascular Stent

Cook Ireland, Ltd. · Decision date Nov 6, 2026

MEDTECHLEDGER EXPLANATIONP050017/S027

What did the FDA decide?

FDA database entry P050017/S027 is a supplement tied to PMA P050017, not a new PMA. The record says the decision was OK30 and the supplement type was a 30-Day Notice for a process change. The changed item is described only as new equipment used for manufacturing packaging; the filing text does not name the equipment, the packaging step, or any changed material.

The original scope named in the record is the Zilver® PTX® Drug-Eluting Peripheral Stent and the Zilver® Vascular Stent. The database text gives the regulatory purpose of the supplement, but it does not state any new indication, clinical outcome, or performance claim.

FDA approval order statement

approval of new equipment used for manufacturing packaging for the Zilver PTX Drug-Eluting Peripheral Stent and Zilver Vascular Stent
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Nov 6, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P050017/S027
Regulatory pathway
PMA supplement
Product code
NIO
Decision code
OK30
Decision date
Nov 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, ILIAC.

Product code
NIO
FDA device class
3

For the original device and its historical approval scope, see PMA P050017. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P050017 · Original PMA

    ZILVER VASCULAR STENT

  2. P050017/S027 received

    Application receipt date recorded by FDA.

  3. P050017/S027 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P050017. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P050017

Product / regulatory recordCompanyPathwayDecision dateSource
Cook Ireland, Ltd.PMA approvalJun 26, 2006FDA

Explore the linked device profile

Other records with product code NIO

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Vascular, Inc.PMA supplementOct 16, 2026FDA
Cordis US CorporationPMA supplementOct 15, 2026FDA
Biotronik AGPMA supplementSep 11, 2026FDA
Biotronik AGPMA approvalDec 17, 2015FDA
Medtronic Vascular, Inc.PMA approvalJun 8, 2004FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cook Ireland, Ltd.

Headquarters
Not reported
Brand website
cookmedical.com
FDA applicant address
O' Halloran Rd., National Technology Park, Limerick

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records